From: Insights in to the pathogenesis of axial spondyloarthropathy based on gene expression profiles
Subject | Dataset | Gender | Race | SpA Likelihood ratio | Medications |
---|---|---|---|---|---|
1 | 1 | M | Asian | 4073 | None (Etanercept withdrawn for 2 months) |
2* | 1 | M | Caucasian | 204 | Simvastatin, cyclobenzaprine, aspirin, indomethacin, atenolol, lansoprazole, hydrocodone |
3 | 1 | M | Caucasian | 204 | _ |
4 | 1 | M | Caucasian | 4073 | _ |
5 | 1 | M | Caucasian | 934 | _ |
6 | 1 | M | Asian | 204 | _ |
7 | 1 | M | Caucasian | 4073 | Metformin, glipizide, atorvastatin, lisinopril, nifedipine, Lantus insulin, Novo Log, sulfasalazine, indomethacin |
8 | 1 | M | Caucasian | 558 | Ibuprofen |
9 | 1 | F | Caucasian | 11383 | Piroxicam, indomethacin |
10 | 1 | F | Caucasian | 7115 | Rofecoxib |
11 | 1 | M | Caucasian | 255 | Acetaminophen, ramipril, omeprazole, aspirin, atorvastatin |
12 | 2 | M | Caucasian | 4073 | Insulin, nifedipine, glipizide, lisinopril, metformin, Vicodin, Flexeril, indomethacin, sulfasalazine |
13 | 2 | F | Caucasian | 1039 | Celecoxib, trazodone, venlafaxine, ranitidine |
14 | 2 | F | Caucasian | 204 | Tobramycin |
15 | 2 | F | Asian | 4073 | Alendronate |
16 | 2 | M | Asian | 204 | _ |
17 | 2 | M | Caucasian | 20774 | Phenylbutazone |
18 | 2 | M | Caucasian | 2308 | Alendronate sodium |